173 related articles for article (PubMed ID: 33785722)
1. Prevalence of BRCA1 and BRCA2 genes promoter hypermethylation in breast cancer tissue.
Lobanova OE; Rossokha ZI; Medvedieva NL; Cheshuk VE; Vereshchako RI; Vershyhora VO; Fishchuk LY; Zakhartseva LM; Gorovenko NG
Exp Oncol; 2021 Mar; 43(1):56-60. PubMed ID: 33785722
[TBL] [Abstract][Full Text] [Related]
2. CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT.
Fishchuk L; Lobanova O; Rossokha Z; Cheshuk V; Vereshchako R; Vagyn Y; Kashuba V; Vershyhora V; Popova O; Levkovich N; Zemlianska O; Ievseienkova O; Podolska S; Gorovenko N
Exp Oncol; 2023 Oct; 45(2):161-169. PubMed ID: 37824776
[TBL] [Abstract][Full Text] [Related]
3. A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.
Evans DGR; van Veen EM; Byers HJ; Wallace AJ; Ellingford JM; Beaman G; Santoyo-Lopez J; Aitman TJ; Eccles DM; Lalloo FI; Smith MJ; Newman WG
Am J Hum Genet; 2018 Aug; 103(2):213-220. PubMed ID: 30075112
[TBL] [Abstract][Full Text] [Related]
4. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J
Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
Kontorovich T; Cohen Y; Nir U; Friedman E
Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
[TBL] [Abstract][Full Text] [Related]
6. Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers.
Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Di Iulio J; Lindeman GJ; Kirk J; Phillips KA; Campbell IG
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):265-74. PubMed ID: 20056647
[TBL] [Abstract][Full Text] [Related]
7. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
[TBL] [Abstract][Full Text] [Related]
8. Methylation not a frequent "second hit" in tumors with germline BRCA mutations.
Dworkin AM; Spearman AD; Tseng SY; Sweet K; Toland AE
Fam Cancer; 2009; 8(4):339-46. PubMed ID: 19340607
[TBL] [Abstract][Full Text] [Related]
9. Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.
Ben Gacem R; Hachana M; Ziadi S; Amara K; Ksia F; Mokni M; Trimeche M
Cancer Epidemiol; 2012 Apr; 36(2):190-7. PubMed ID: 21978880
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 carriers with male breast cancer show elevated tumour methylation.
Deb S; Gorringe KL; Pang JB; Byrne DJ; Takano EA; ; Dobrovic A; Fox SB
BMC Cancer; 2017 Sep; 17(1):641. PubMed ID: 28893223
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
[TBL] [Abstract][Full Text] [Related]
12. Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer.
Hansmann T; Pliushch G; Leubner M; Kroll P; Endt D; Gehrig A; Preisler-Adams S; Wieacker P; Haaf T
Hum Mol Genet; 2012 Nov; 21(21):4669-79. PubMed ID: 22843497
[TBL] [Abstract][Full Text] [Related]
13. Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer.
Lobanova O; Medvedieva N; Fishchuk L; Dubitska O; Cheshuk V; Vereshchako R; Zakhartseva L; Rossokha Z; Gorovenko N
Breast Cancer Res Treat; 2022 Dec; 196(3):505-515. PubMed ID: 36284026
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.
Burke LJ; Sevcik J; Gambino G; Tudini E; Mucaki EJ; Shirley BC; Whiley P; Parsons MT; De Leeneer K; Gutiérrez-Enríquez S; Santamariña M; Caputo SM; Santana Dos Santos E; Soukupova J; Janatova M; Zemankova P; Lhotova K; Stolarova L; Borecka M; Moles-Fernández A; Manoukian S; Bonanni B; ; Edwards SL; Blok MJ; van Overeem Hansen T; Rossing M; Diez O; Vega A; Claes KBM; Goldgar DE; Rouleau E; Radice P; Peterlongo P; Rogan PK; Caligo M; Spurdle AB; Brown MA
Hum Mutat; 2018 Dec; 39(12):2025-2039. PubMed ID: 30204945
[TBL] [Abstract][Full Text] [Related]
15. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
Arif T; Anwar N
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
[TBL] [Abstract][Full Text] [Related]
16. Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients.
Rodríguez-Balada M; Roig B; Melé M; Salvat M; Martorell L; Borràs J; Gumà J
Clin Transl Oncol; 2018 Sep; 20(9):1226-1231. PubMed ID: 29404838
[TBL] [Abstract][Full Text] [Related]
17. Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
Scott CM; Joo JE; O'Callaghan N; Buchanan DD; Clendenning M; Giles GG; Hopper JL; Wong EM; Southey MC
PLoS One; 2016; 11(11):e0165436. PubMed ID: 27902704
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature.
Aref-Eshghi E; McGee JD; Pedro VP; Kerkhof J; Stuart A; Ainsworth PJ; Lin H; Volodarsky M; McLachlin CM; Sadikovic B
J Hum Genet; 2020 Oct; 65(10):865-873. PubMed ID: 32483276
[TBL] [Abstract][Full Text] [Related]
19. Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.
Zhou C; Porter N; Borges M; Gauthier C; Ferguson L; Huang B; Nanda N; He J; Laheru D; Hruban RH; Goggins M; Klein AP; Roberts NJ
Pancreatology; 2021 Aug; 21(5):938-941. PubMed ID: 33839031
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]